戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 e exacerbations of COPD as add-on therapy to standard drugs.
2 ating and NR Mtb, including Mtb resistant to standard drugs.
3  H; IC(50) = 3.08 muM; 6.6- and 3.1-fold the standard drugs, 5-fluorouracil and sunitinib, respective
4 7.059 ug/mL), surpassing the efficacy of the standard drug acarbose (IC50: 77.42 ug/mL).These multifu
5 tivity of sunitinib, the clinically approved standard drug) also has significant activity against pan
6 ses, and tumor blood vessels compared with a standard drug and with control and thus demonstrated pot
7       Toxicity and drug likeness activity of standard drugs and phytoconstituents was done by using o
8 xploited as an adjunct therapy together with standard drug-based approaches.
9 urvived; it was also more effective than the standard drug benznidazole.
10 asty (percutaneous transluminal angioplasty [standard], drug-coated balloon), stenting (bare metal, d
11 ergo allo HSCT before resistance develops to standard drug combinations.
12 mple platform was validated against an LC-MS standard drug detection method in samples from healthy v
13 hAChEIs (IC50 up to 3 nM), outperforming the standard drug donepezil (IC50 = 11 nM), most of the corr
14 keness and no toxicity than the FDA-approved standard drug, Donepezil.
15 drop of intraocular pressure compared to the standard drug dorzolamide.
16  progress has been made, notably in terms of standard drug dose intensification and safer allogeneic
17  compounds were much more effective than the standard drug doxorubicin (DXN).
18 steatosis when compared to the effect of the standard drug fenofibrate.
19 Here, we show that low doses of metformin, a standard drug for diabetes, inhibits cellular transforma
20 BAA receptor-positive modulator, is the gold-standard drug for treating insomnia.
21 the triple-drug group and 64% (53-74) in the standard drug group, and at 4 years it was 59% in the tr
22  to 53.12, which is improved compared to the standard drug Miltefosine (IC(50) 12.4 muM and SI 4.1).
23 inating, 16 is 480-fold more potent than the standard drug pentamidine (IC(50) = 5.3 nM).
24 , and current field sobriety tests with gold-standard, drug recognition evaluations are resource-inte
25  MDR or XDR tuberculosis in combination with standard drug regimens.
26 ant tuberculosis (MDR-TB) in comparison with standard drug susceptibility testing (DST) and compared
27 ere subjected to whole genome sequencing and standard drug susceptibility testing for eleven anti-TB
28 iated genes) were strongly enriched for gold-standard drug target and Mendelian disease genes.
29 ctivity, yet its mode of action differs from standard drugs that are currently in use.
30 , intransigent tumors that barely respond to standard drug therapies.
31 opriate for patients who do not do well with standard drug therapy or for those who prefer a disease-
32 ial of aerosol IFN-gamma in conjunction with standard drug therapy, we have observed activation of IF
33 ome patients having little or no response to standard drug therapy.
34 ed murine pancreatic islets by more than the standard drug tolbutamide, showing that they are potenti
35                                              Standard drug treatment for OH is effective but worsens
36 is clinically better than carbamazepine, the standard drug treatment, for time to treatment failure o